학술논문

NXP900, a novel YES1/SRC kinase inhibitor demonstrates inhibition of YAP1 nuclear localization and potent single agent anti-tumor activity in esophageal squamous cancer models
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2023, 22 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514